Cargando…
28 Experiences of using Paxlovid to treat clinically extremely vulnerable non-hospitalised patients with COVID-19
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469073/ http://dx.doi.org/10.1016/j.clinpr.2022.100189 |
| _version_ | 1784788557718618112 |
|---|---|
| author | Gahir, Joshua Saund, Jasjot Brown, Michael Harchowal, Jatinder Waters, Laura |
| author_facet | Gahir, Joshua Saund, Jasjot Brown, Michael Harchowal, Jatinder Waters, Laura |
| author_sort | Gahir, Joshua |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9469073 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94690732022-09-13 28 Experiences of using Paxlovid to treat clinically extremely vulnerable non-hospitalised patients with COVID-19 Gahir, Joshua Saund, Jasjot Brown, Michael Harchowal, Jatinder Waters, Laura Clin Infect Pract Article Elsevier Ltd 2022-09 2022-09-13 /pmc/articles/PMC9469073/ http://dx.doi.org/10.1016/j.clinpr.2022.100189 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Gahir, Joshua Saund, Jasjot Brown, Michael Harchowal, Jatinder Waters, Laura 28 Experiences of using Paxlovid to treat clinically extremely vulnerable non-hospitalised patients with COVID-19 |
| title | 28 Experiences of using Paxlovid to treat clinically extremely vulnerable non-hospitalised patients with COVID-19 |
| title_full | 28 Experiences of using Paxlovid to treat clinically extremely vulnerable non-hospitalised patients with COVID-19 |
| title_fullStr | 28 Experiences of using Paxlovid to treat clinically extremely vulnerable non-hospitalised patients with COVID-19 |
| title_full_unstemmed | 28 Experiences of using Paxlovid to treat clinically extremely vulnerable non-hospitalised patients with COVID-19 |
| title_short | 28 Experiences of using Paxlovid to treat clinically extremely vulnerable non-hospitalised patients with COVID-19 |
| title_sort | 28 experiences of using paxlovid to treat clinically extremely vulnerable non-hospitalised patients with covid-19 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469073/ http://dx.doi.org/10.1016/j.clinpr.2022.100189 |
| work_keys_str_mv | AT gahirjoshua 28experiencesofusingpaxlovidtotreatclinicallyextremelyvulnerablenonhospitalisedpatientswithcovid19 AT saundjasjot 28experiencesofusingpaxlovidtotreatclinicallyextremelyvulnerablenonhospitalisedpatientswithcovid19 AT brownmichael 28experiencesofusingpaxlovidtotreatclinicallyextremelyvulnerablenonhospitalisedpatientswithcovid19 AT harchowaljatinder 28experiencesofusingpaxlovidtotreatclinicallyextremelyvulnerablenonhospitalisedpatientswithcovid19 AT waterslaura 28experiencesofusingpaxlovidtotreatclinicallyextremelyvulnerablenonhospitalisedpatientswithcovid19 |